Recon: Lawmakers press FDA on Lykos MDMA drug ahead of PDUFA date; FDA approves Adaptimmune’s Tecelra for rare cancer
ReconMichael Mezher
Approval/marketing authorizationBiologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicySubmission and registrationUnited StatesUS Food and Drug Administration (FDA)